A Study of ADR-001 in Patients With Liver Cirrhosis

Clinical trial NCT03254758 · COMPLETED

Trial details

NCT number: NCT03254758
Sponsor: Rohto Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Decompensated Liver Cirrhosis

Start date: 2017-07-20
Primary completion: 2023-04-13
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.